Leonard Barasa to Structure-Activity Relationship
This is a "connection" page, showing publications Leonard Barasa has written about Structure-Activity Relationship.
Connection Strength
0.469
-
Barasa L, DeOrsey L, O'Reilly MD, Choudhary S, Cahill SE, Mathur A, Allabaji A, Nellikkalaya S, Paul S, Vidadala SR, Sarkar SK, Rajendran M, Patil SN, Kalonia H, Hale J, Humphries F, Fitzgerald KA, Thompson PR. Development of UM-200: A Novel Alkyne Amide-Based Inhibitor of the cGAS-STING Pathway. J Med Chem. 2026 Apr 09; 69(7):8561-8582.
Score: 0.222
-
Barasa L, Vemana HP, Surubhotla N, Ha SS, Kong J, Yong A, Croft JL, Dukhande VV, Yoganathan S. Synthesis and Biological Evaluation of Structurally Diverse Benzimidazole Scaffolds as Potential Chemotherapeutic Agents. Anticancer Agents Med Chem. 2020; 20(3):301-314.
Score: 0.144
-
Singh A, Barasa L, DeOrsey L, O'Reilly MD, Choudhary S, Cahill SE, Rossetti T, Green RM, Humphries F, Thompson PR. Triazole-based STING inhibitors. Bioorg Med Chem. 2026 Jan 01; 132:118484.
Score: 0.054
-
Karadkhelkar NM, Gupta P, Barasa L, Chilamakuri R, Hlordzi CK, Acharekar N, Agarwal S, Chen ZS, Yoganathan S. Chemical Derivatization Leads to the Discovery Of Novel Analogs of Azotochelin, a Natural Siderophore, as Promising Anticancer Agents. ChemMedChem. 2024 Jul 02; 19(13):e202300715.
Score: 0.049